Temperature Control Distribution

The European market presents a complex supply chain, from varying import/export requirements, tax, VAT and custom duties, differing country legislation regarding physical distribution of drug product to temperature extremities impacting how the drug product is shipped.
There is no “one size fits all” supply chain. Pharmaceutical companies are developing tailored supply chains depending on product type (orphan drug / generic / patented / controlled drugs etc.) and/or by channel (wholesale, direct to pharmacy, direct to patient, etc). This is particularly true, with high value orphan drug products.
Download this case study to learn how a US company partnered with Almac to successfully launch their temperature sensitive orphan drug product in the EU marketplace with a tailored shipping solution to fully meet the distribution requirements of their direct to pharmacy 3PL supply chain.